Key Finding
30 out of 31 randomized controlled trials reported improvement in at least one PCOS-related outcome — including hormones, menstrual frequency, insulin sensitivity, and fertility — following acupuncture treatment.
If you have been diagnosed with polycystic ovary syndrome (PCOS), you may already know how challenging it can be to manage symptoms like irregular periods, hormonal imbalances, weight fluctuations, and fertility struggles. Researchers have been exploring whether acupuncture — a traditional practice involving the gentle insertion of thin needles into specific points on the body — might offer meaningful relief.
A comprehensive review published in the Journal of Zhejiang University examined 31 clinical trials that looked at acupuncture as a treatment for PCOS. Researchers searched multiple major medical databases to find the best available evidence, comparing acupuncture against no treatment, sham (fake) acupuncture, standard medications, or a combination approach.
The results were encouraging. Thirty out of 31 trials showed improvement in at least one PCOS-related measurement after acupuncture treatment. These measurements included menstrual regularity, hormone levels, body weight and measurements, insulin sensitivity, blood lipid levels, and fertility outcomes. In other words, across a wide range of PCOS symptoms, acupuncture appeared to make a positive difference for many patients.
However, the researchers were careful to note that the quality and design of many of these studies varied significantly, making it difficult to draw firm conclusions. Not all trials followed the same methods or reported results in the same way, which limits how confidently we can say acupuncture definitively treats PCOS. The authors used their findings to create guidelines for better-designed studies in the future, which should give us clearer answers.
For now, acupuncture looks like a promising complementary option for women managing PCOS — particularly for those who want to support their conventional treatment with a holistic approach. If you are considering acupuncture for PCOS, seek out a licensed and experienced acupuncturist who has worked with hormonal and reproductive health conditions.
This systematic review of 31 RCTs evaluated acupuncture as an intervention for polycystic ovary syndrome (PCOS), drawing from eight major databases including MEDLINE, EMBASE, CNKI, and Wanfang. Trials were categorized into four groups based on comparator type: no intervention, sham acupuncture, pharmacological treatment, and acupuncture plus conventional therapy versus conventional therapy alone. Primary outcomes included menstrual frequency, reproductive hormones, anthropometrics, insulin sensitivity, lipid profiles, and fertility markers. Notably, 30 of 31 included trials demonstrated improvement in at least one PCOS-related outcome measure following acupuncture treatment. No specific effect sizes were reported in the abstract. The authors identify significant methodological heterogeneity and inconsistent reporting standards across trials as key limitations, preventing definitive meta-analytic conclusions. The clinical takeaway is that acupuncture shows broad-spectrum potential across multiple PCOS domains, but practitioners should advocate for and participate in well-designed, standardized RCTs to strengthen the evidence base.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A systematic review of 214 studies found that acupuncture and moxibustion improve endometrial receptivity in IVF-ET patients by enhancing uterine lining thickness, blood flow, and hormone levels through multiple molecular mechanisms including VEGF-mediated angiogenesis and AMPK/mTOR autophagy pathways.
📌 Live birth rate — the outcome most important to patients undergoing acupuncture-assisted IVF — remains one of the least-supported measures in existing clinical trial evidence, highlighting a critical gap between research priorities and patient concerns.
📌 Acupoint application therapy significantly increased high-quality embryo rates to 47% in ovarian endometriosis IVF patients compared to 31% in the placebo group, while normalizing dysregulated follicular steroid hormone levels linked to impaired oocyte yield.